Reddy RC, Baptist AP, Fan Z, Carlin AM, Birkmeyer NJ
Their study also showed that nearly 40% of GLP-1 users experience gastrointestinal side effects nausea, vomiting, diarrhea, constipation, and altered appetite and satiety regulation
For GLP-1 medications, studies such as the STEP trials for semaglutide and the SURMOUNT trials for tirzepatide showed that higher doses generally produce greater average weight loss and metabolic improvements
These medications have had a significant impact for many of the people who take them and have broken the endless cycle of dieting and weight cycling that marks the efforts of so many who try and fail to lose weight in an effort to improve their health
I reviewed the literature and determined the dosage that we could apply directly into patients sores and ulcers